ENDOSCOPIC THIRD VENTRICULOSTOMY FOR AQUEDUCTAL STENOSIS IN CHILDREN BETWEEN SIX TO TWELVE MONTHS OF AGE

Sharma Shipra; Sahu Rajiv; Sahana Debabrata; Gupta Gaurav; Kumar Sanjeev; Jain Amit

Volume : VII, Issue : II, February - 2018

ENDOSCOPIC THIRD VENTRICULOSTOMY FOR AQUEDUCTAL STENOSIS IN CHILDREN BETWEEN SIX TO TWELVE MONTHS OF AGE

Sharma Shipra, Sahu Rajiv, Sahana Debabrata, Gupta Gaurav, Kumar Sanjeev, Jain Amit

Abstract :

Introduction – Hydrocephalus can affect humans even before birth. Many causes have been identified of which aqueductal stenosis has been found in 15% to 60 %of cases. Treatment involves shunt surgery, which is plagued by complications such as shunt malfunction and infections. Of late endoscopic third ventriculostomy has been found to be very effective in aqueductal stenosis. The success rate of ETV in infants varies from series to series. This study analyses the outcomes of ETV in the age group of 6 to 12 months.

Materials and methods– This was a prospective study carried out atDr. B.R.A.M. Hospital, Raipur from March 2015 to September 2016.It comprised of 42 children in the age group of 6 months to 1 year having hydrocephalus due to aqueductal stenosis. They were treated with ETV. Results and complications wereanalysed. They were followed up after surgery upto their discharge & at one month after that.

Results– Of42 patients with aqueductal stenosis who underwent ETV,22 were between 6 to 9 months of age and 20 were between 9 to 12 months of age. The incidence of infective complications in ETV was found to be 8%. None of the patients at discharge showed signs and symptoms of failure but 9 of them presented with such signs and symptoms at the end of 1 month. Of these 6(66.67% of failures) were in the age group of 6 to 9 months and 3(33.3% of failures) in the age of group of 9 to 12 months.The difference was not found to be statistically significant (Chi square – 0.350) although there clearly is a trend towards better success rates in the older age group.

.

Conclusion –In the age group of 6 months to one year, ETV has excellent outcomes and lesser complications for aqueductal stenosis, with a trend towards better outcomes as age increases.